Jun 2026 (Q2 FY26) — Aug 13, 2026
Health In Tech Q2 FY26 — Strategic Investments and Future Revenue Visibility Amidst Timing Shifts
Read the full callHealth In Tech (HIT) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Health In Tech earnings: last reported Thu, 13 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 8.1 | −13.5% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | Operating profit / revenue | Quarter to Jun 2026 | Not in the filed figures for the quarter to jun 2026. No older figure is substituted. | ||
| Net profit | -2.5 | −498.2% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
$0.64 −1.54% · −$0.01
Performance −78.8% 1Y
1Y: $3.02 on 17 Oct 2025 → $0.64. High $3.17 (20 Oct 2025), low $0.63 (15 Oct 2026).
- Previous close
- $0.65
- 52-week range
- $0.63 – $3.17
- One year
- −79.81%
Overview
- Symbol
- HIT
- Sector
- Information Technology
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Health In Tech earnings calls (HIT)
Financials
What the filings say
Net profit, year on year: −498% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 4 | 5 | 8 | 9 | 8 | 8 | 9 | 8 |
| Other income | -0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 |
| Interest | 0 | 0 | — | — | — | — | — | — |
| Profit before tax | 0 | -0 | 1 | 1 | 1 | -0 | -2 | -3 |
| Tax rate | 7.5% | −30.2% | 27.1% | 24.3% | 24.7% | 31.8% | 23.2% | 24.4% |
| Net profit | 0 | -0 | 0 | 1 | 0 | -0 | -2 | -3 |
| EPS ($ per share) | 0.01 | — | 0.01 | 0.01 | 0.01 | — | -0.03 | -0.04 |
| Line item | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Reserves | 3 | 4 | 5 |
| Total liabilities | 5 | 3 | 6 |
| Total assets | 12 | 16 | 23 |
| Line item | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Cash from operations | 2 | 2 | 3 |
| Cash from investing | -2 | -1 | -3 |
| Cash from financing | 1 | 4 | -0 |
Insider filings
36 filings between Nov 5, 2025 and Oct 7, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$37.7K
4 sales by 2 insiders
25% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 14
- Award — granted as compensation
- 18
- Tax withheld — shares kept back by the company to cover tax
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Hayes Timothy | — | $27.0K | Sep 14, 2026 |
| Hasan Zain Syed | — | $10.7K | Sep 11, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 7, 2026 | Hayes Timothy Director | Award | 26,301 | $20.0K |
| Oct 7, 2026 | Howard William D. Director | Award | 26,301 | $20.0K |
| Sep 15, 2026 | Qian LinLin Chief Executive Officer | Tax withheld | 33,725 | $30.0K |
| Sep 15, 2026 | Johnson Tim Donald Chief Executive Officer | Tax withheld | 63,339 | $56.4K |
| Sep 15, 2026 | Hasan Zain Syed Chief Growth Officer | Tax withheld | 4,795 | $4.3K |
| Sep 14, 2026 | Hayes Timothy Director | Sale | 12,000 | $10.7K |
| Sep 11, 2026 | Hasan Zain Syed Chief Growth Officer | Sale 10b5-1 plan | 11,667 | $10.7K |
| Sep 11, 2026 | Hayes Timothy Director | Sale | 12,000 | $10.9K |
| Sep 9, 2026 | Hayes Timothy Director | Sale | 5,730 | $5.3K |
| Aug 13, 2026 | Hasan Zain Syed Chief Growth Officer | Tax withheld | 4,007 | $4.2K |
| Aug 13, 2026 | Qian LinLin Chief Financial Officer | Tax withheld | 28,183 | $29.9K |
| Aug 13, 2026 | Johnson Tim Donald Chief Executive Officer | Tax withheld | 46,327 | $49.1K |
| Jul 15, 2026 | Johnson Tim Donald Chief Executive Officer | Tax withheld | 47,217 | $49.1K |
| Jul 15, 2026 | Qian LinLin Chief Financial Officer | Tax withheld | 28,725 | $29.9K |
| Jul 15, 2026 | Hasan Zain Syed Chief Growth Officer | Tax withheld | 4,084 | $4.2K |
| Jul 8, 2026 | Hayes Timothy Director | Award | 18,867 | $20.0K |
| Jul 8, 2026 | Howard William D. Director | Award | 18,867 | $20.0K |
| Jul 8, 2026 | Shrestha Sanjay K Director | Award | 18,867 | $20.0K |
| Jun 15, 2026 | Johnson Tim Donald Chief Executive Officer | Tax withheld | 46,768 | $49.1K |
| Jun 15, 2026 | Qian LinLin Chief Financial Officer | Tax withheld | 28,451 | $29.9K |
| Jun 15, 2026 | Hasan Zain Syed Chief Growth Officer | Tax withheld | 4,045 | $4.2K |
| May 20, 2026 | Lockett Jonathan Del Chief Strategy Officer | Award | 50,000 | $0 |
| May 14, 2026 | Hasan Zain Syed Chief Growth Officer | Tax withheld | 4,205 | $5.2K |
| May 14, 2026 | Johnson Tim Donald Chief Executive Officer | Tax withheld | 39,924 | $49.1K |
| May 14, 2026 | Qian LinLin Chief Financial Officer | Tax withheld | 23,324 | $28.7K |
| Apr 15, 2026 | Johnson Tim Donald Chief Executive Officer | Tax withheld | 35,140 | $52.7K |
| Apr 15, 2026 | Qian LinLin Chief Financial Officer | Tax withheld | 21,480 | $32.2K |
| Apr 15, 2026 | Hasan Zain Syed Chief Growth Officer | Tax withheld | 3,448 | $5.2K |
| Apr 10, 2026 | McStravock John General Counsel | Award | 5,000 | $0 |
| Apr 8, 2026 | Hayes Timothy Director | Award | 13,598 | $18.5K |
| Apr 8, 2026 | Howard William D. Director | Award | 13,598 | $18.5K |
| Apr 8, 2026 | Shrestha Sanjay K Director | Award | 13,598 | $18.5K |
| Jan 6, 2026 | Qian LinLin Chief Financial Officer | Award | 1,000,000 | $0 |
| Jan 6, 2026 | Johnson Tim Donald Chief Executive Officer | Award | 1,000,000 | $0 |
| Jan 6, 2026 | Hasan Zain Syed Chief Growth Officer | Award | 200,000 | $0 |
| Nov 5, 2025 | Clarkson Michael David CISO | Award | 8,000 | $0 |
| Oct 8, 2025 | Howard William D. Director | Award | 5,730 | $20.0K |
| Oct 8, 2025 | Hayes Timothy Director | Award | 5,730 | $20.0K |
| Oct 8, 2025 | Shrestha Sanjay K Director | Award | 5,730 | $20.0K |
| Oct 3, 2025 | Howard William D. Director | Disposition to issuer | 28,159 | $0 |
| Oct 3, 2025 | Hayes Timothy Director | Disposition to issuer | 28,159 | $0 |
| Oct 3, 2025 | Shrestha Sanjay K Director | Disposition to issuer | 65,469 | $0 |
| Sep 24, 2025 | Johnson Tim Donald Chief Executive Officer | Award | 80,000 | $0 |
| Sep 24, 2025 | Plantholt Dustin Chief AI & Marketing Officer | Award | 50,000 | $0 |
| Sep 24, 2025 | Qian LinLin Chief Financial Officer | Award | 80,000 | $0 |
| Aug 15, 2025 | Qian LinLin Chief Financial Officer | Award | 27,000 | $0 |
| Aug 15, 2025 | Johnson Tim Donald Chief Executive Officer | Award | 34,000 | $0 |
| Aug 15, 2025 | Yousuf Imran Mohammed Chief Technology Officer | Award | 7,000 | $0 |
| Aug 15, 2025 | Lockett Jonathan Del Chief Strategy Officer | Award | 7,000 | $0 |
| Jun 23, 2025 | Hayes Timothy Director | Award | 128,474 | $79.7K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Health In Tech, Inc.
Free account. Everything above stays public.
Write why you follow Health In Tech, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading